טוען...
Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells
Huntington's disease (HD) is a neurodegenerative condition characterized by pathology in the brain and peripheral tissues. Hyperactivity of the innate immune system, due in part to NFκB pathway dysregulation, is an early and active component of HD. Evidence suggests targeting immune disruption...
שמור ב:
| הוצא לאור ב: | J Neurochem |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4982105/ https://ncbi.nlm.nih.gov/pubmed/26823290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jnc.13553 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|